Experts explain the science behind Biden's advanced prostate cancer diagnosis, including how common it is and what treatments are available.

Five- and eight-year trial data to be presented at ASCO demonstrate durable survival outcomes with Xtandi (enzalutamide) plus ...

There are 5 groups, from CPG1 to CPG5. Some doctors may still use an older, different system. This divides prostate cancer into 3 risk groups. In this system, risk refers to how likely it is that ...

In light of former President Biden's prostate cancer diagnosis, retired journalist Jim Ware details his own journey.

A prostate cancer diagnosis can feel overwhelming, but the growing number of targeted treatments means patients (and their ...

In a post-hoc analysis from the Phase III ARANOTE trial, new results show metastatic castration-sensitive prostate cancer ...

Standard medical practice is to not test men who have a life expectancy of less than 10 years for prostate cancer.

Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, ...

The objective of this study was to assess whether adding CAN-2409 in combination with the prodrug valacyclovir to standard of ...

The idea that a man could receive regular exams and still wind up with a late-stage discovery? It doesn’t surprise me at all.

Doctors encourage Pennsylvania’s men to get prostate cancer screenings before symptoms appear.